Michael Arustamyan
Cardiovascular Disease · New York, NYNPI 1811489891
Payments from drug & device makers
Across 117 payments — averaging $55.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medtronic$1K
- Boston Scientific$1K
- Cardiva Medical, Inc.$325
- Penumbra, Inc.$238
- Abiomed$210
- plus $822 from 11 others
What the payments were for
- Travel & lodging$96415%
- Food & beverage$5,39482%
- Education$1903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 35 | $2,600 |
| Medtronic | 16 | $1,339 |
| Boston Scientific | 21 | $1,015 |
| Cardiva Medical, Inc. | 13 | $325 |
| Penumbra, Inc. | 4 | $238 |
| Abiomed | 6 | $210 |
| Shockwave Medical, Inc | 4 | $195 |
| Imperative Care, Inc | 1 | $139 |
| Getinge USA Sales, LLC | 3 | $107 |
| Cook Medical LLC | 3 | $78 |
| Stryker | 2 | $71 |
| Heartflow, Inc. | 3 | $69 |
| Teleflex LLC | 2 | $49 |
| Kestra Medical Technology Services, Inc. | 1 | $43 |
| Surmodics, Inc. | 1 | $31 |
| Chiesi USA, Inc. | 1 | $24 |
| Biotronik Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,548 in reported general payments places this provider in the 75th percentile of 2,302 cardiovascular disease providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 18 | $10,759 |
| Spironolactone | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in New York
- James MinNew York$41.1M
- Robert RosensonNew York$6.9M
- Roxana MehranNew York$6.4M
- Roger HajjarNew York$5.2M
- Philippe GenereuxNew York$4.4M
- Gregg StoneNew York$3.7M
- Valentin FusterNew York$2.9M
- Tamim NazifNew York$2.2M
- Howard WeintraubNew York$1.7M
- Anuradha Lala-TrindadeNew York$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.